This inventor holds 46 USPTO granted patents and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Sanofi, Sanofi-Synthelabo, Elf Sanofi. Active years: 1988-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Montpellier, FR (1988 - 1989)
- La Balajade, FR (1997)
- Combaillaux, FR (1994 - 2009)
Company Filing History:
28 out of 1,549 
9 out of 152 
4 out of 53 
Years Active: 1988-2009
Areas of Expertise:
Title: Xavier Emonds-Alt: Innovative Inventor and Prolific Patent Holder
Introduction:
Xavier Emonds-Alt, hailing from Combaillaux, France, is a highly regarded inventor and patent holder in the field of pharmaceuticals. With an impressive count of 46 patents to his name, Emonds-Alt has made groundbreaking contributions to the development of novel therapeutic compounds. In this article, we will delve into his latest patents, career highlights, notable collaborations, and celebrate his significant achievements.
Latest Patents:
Among his recent patents, two noteworthy inventions stand out:
1. "4-arylmorpholin-3-one derivatives, their preparation, and therapeutic use thereof": This patent describes compounds represented by formula (I), along with methods for their synthesis, formulations incorporating them, and therapeutic applications. These compounds exhibit potential for therapeutic use, particularly in the treatment or prevention of various mood disorders, adaptation disorders, and mixed anxiety-depression disorders.
2. "Use of saredutant and its pharmaceutically acceptable salts for the preparation of medicinal products for treating mood disorders and anxiety-depression disorders": This invention emphasizes the utilization of saredutant and its salts for the formulation of medicinal products. These products prove beneficial in the treatment and prevention of mood disorders, adaptation disorders, and mixed anxiety-depression disorders. The patent highlights the pharmaceutical applications of saredutant and underlines its potential therapeutic significance.
Career Highlights:
Xavier Emonds-Alt has had a distinguished career, with significant contributions to the field of pharmaceuticals. He has lent his expertise to renowned companies such as Sanofi (formerly known as Sanofi-Synthelabo).
Collaborations:
Throughout his career, Emonds-Alt has had the privilege of working with accomplished colleagues, some of whom include:
1. Vincenzo Proietto: A respected professional in the pharmaceutical industry, Proietto has collaborated with Emonds-Alt on various projects, contributing to their mutual success.
2. Didier Van Broeck: Another esteemed collaborator, Van Broeck has worked alongside Emonds-Alt, sharing their knowledge and expertise to further advancements in the field of pharmaceuticals.
Conclusion:
Xavier Emonds-Alt, a prolific inventor and patent holder, has made significant contributions to the field of pharmaceuticals. With an impressive count of 46 patents and ongoing innovation, Emonds-Alt's work has the potential to address a range of mood disorders, adaptation disorders, and mixed anxiety-depression disorders. His collaborations with esteemed professionals have further enhanced his achievements, showcasing his commitment to innovation and progress in the pharmaceutical industry. We eagerly anticipate Emonds-Alt's future contributions and groundbreaking inventions that will continue to make a positive impact on the lives of many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile